Clinical Trials Browser

OTHER × Interventional × Tuberous Sclerosis × Clear all

NCT02104011 2026-05-19

STBETA

Phase 2 Completed

Tuberous Sclerosis

NCT07561957 2026-05-01

A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines

Phase NA Recruiting

Kidney Diseases, Nephrotic Syndrome, Proteinuria, Tuberous Sclerosis, Renal Insufficiency, Chronic

NCT06311474 2026-03-18

RAINBOW

Phase NA Completed

Mental Disorders, Tuberous Sclerosis

NCT06139172 2026-01-23

Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)

Phase NA Recruiting

Creatine deficiency, X-linked, Telomeric 22q13 Monosomy Syndrome, Chromosome 15q, partial deletion, Fragile X Syndrome, Hamartoma Syndrome, Multiple, Tuberous Sclerosis, Rett Syndrome, Angelman Syndrome

NCT05104983 2026-01-22

TSC-STEPS

Phase 2 Recruiting

Epilepsy, Tuberous Sclerosis

NCT05467397 2026-01-21

Feasibility of [11C]Acetate-PET in LAM and TSC

Phase 1/2 Active not recruiting

7 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT06879665 2025-09-22

TANDem-2

Phase NA Enrolling by invitation

Tuberous Sclerosis

NCT03836300 2025-07-31

Parent and Infant Inter(X)Action Intervention (PIXI)

Phase NA Enrolling by invitation

Telomeric 22q13 Monosomy Syndrome, Developmental Disabilities, DiGeorge Syndrome, Down Syndrome, Fragile X Syndrome, Klinefelter Syndrome, Prader-Willi Syndrome, Tuberous Sclerosis, Turner Syndrome, Rett Syndrome, Angelman Syndrome, Williams Syndrome, Muscular Dystrophy, Duchenne, Smith-Magenis Syndrome

NCT06081348 2025-07-16

CALM

Phase 2 Recruiting

Autism Spectrum Disorder, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Autistic Disorder, DiGeorge Syndrome, Fragile X Syndrome, Tourette Syndrome, Tic Disorders, Tuberous Sclerosis, 22q11 Deletion Syndrome, Neurodevelopmental Disorders

NCT04698538 2024-10-30

TRAIN

Phase NA Completed

Tuberous Sclerosis

NCT02849457 2024-08-19

Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex

Phase 2 Completed

84 enrolled 16 charts

Tuberous Sclerosis

NCT04595513 2024-05-16

STOP2

Phase 1/2 Completed

5 enrolled 15 charts

Epilepsy, Tuberous Sclerosis

NCT05867576 2024-02-14

ACT in TSC

Phase NA Unknown

Psychological Well-Being, Tuberous Sclerosis

NCT04987463 2024-02-08

ViRap

Phase 2/3 Unknown

Epilepsy, Neoplasms, Tuberous Sclerosis

NCT04344626 2023-10-10

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Phase NA Withdrawn

Focal Cortical Dysplasia, Brain Neoplasms, Encephalitis, Epilepsy, Gliosis, Sturge-Weber Syndrome, Tuberous Sclerosis, Stroke, Hemimegalencephaly, Polymicrogyria

NCT05534672 2023-08-08

RaRE-TS

Phase 3 Recruiting

Drug Resistant Epilepsy, Epilepsy, Tuberous Sclerosis

NCT00126672 2022-04-25

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

Phase 2 Completed

36 enrolled 8 charts

Neoplasms, Tuberous Sclerosis, Angiomyolipoma

NCT02451696 2021-09-01

A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD

Phase 2 Completed

15 enrolled 9 charts

Focal Cortical Dysplasia, Epilepsy, Tuberous Sclerosis

NCT02860494 2021-05-03

EVEROST

Phase 2/3 Withdrawn

Tuberous Sclerosis

NCT01929642 2021-03-29

RAPT

Phase 2 Completed

3 enrolled 10 charts

Autistic Disorder, Tuberous Sclerosis, Self-Injurious Behavior

NCT03422367 2020-11-06

JETS

Phase NA Unknown

Autistic Disorder, Child Development Disorders, Pervasive, Epilepsy, Tuberous Sclerosis

NCT01526356 2020-10-26

Treatment

Phase 2 Completed

179 enrolled 13 charts

Tuberous Sclerosis, Angiofibroma

NCT02201212 2020-09-16

Everolimus for Cancer With TSC1 or TSC2 Mutation

Phase 2 Completed

30 enrolled 12 charts

Tuberous Sclerosis

NCT02061397 2020-08-25

SOS

Phase 1/2 Completed

10 enrolled 6 charts

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT03356769 2020-06-09

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Phase 2 Unknown

Epilepsy, Seizures, Tuberous Sclerosis, Cognitive Dysfunction

NCT03326765 2018-10-17

Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)

Phase NA Unknown

Sleep Wake Disorders, Tuberous Sclerosis

NCT02687633 2018-05-02

Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex

Phase NA Completed

Tuberous Sclerosis

NCT03254680 2018-04-30

Turmeric as Treatment in Epilepsy

Phase NA Withdrawn

Epilepsy, Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT01954693 2018-01-30

TRON

Phase 2 Unknown

Tuberous Sclerosis

NCT01289912 2018-01-25

TSC

Phase 2 Completed

52 enrolled 12 charts

Autistic Disorder, Tuberous Sclerosis

NCT01266291 2017-07-12

STARS

Phase 4 Terminated

1 enrolled 8 charts

Seizures, Tuberous Sclerosis

NCT03140449 2017-05-04

Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis

Phase 3 Completed

Tuberous Sclerosis

NCT01070316 2017-03-13

Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)

Phase 1/2 Completed

20 enrolled 8 charts

Epilepsy, Hereditary Sensory and Autonomic Neuropathies, Tuberous Sclerosis

NCT01853423 2016-08-19

Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream

Phase 1 Completed

Tuberous Sclerosis, Angiofibroma

NCT00989742 2015-12-02

Doxycycline In Lymphangioleiomyomatosis (LAM)

Phase 4 Completed

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT01730209 2015-05-05

RAPIT

Phase 2/3 Unknown

Autistic Disorder, Intellectual Disability, Tuberous Sclerosis

NCT00411619 2014-10-20

Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

Phase 1/2 Completed

28 enrolled 7 charts

Astrocytoma, Hereditary Sensory and Autonomic Neuropathies, Tuberous Sclerosis

NCT02098759 2014-04-04

EPISTOP

Phase NA Unknown

Epilepsy, Tuberous Sclerosis

NCT00457964 2013-09-25

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

Phase 1/2 Completed

Hereditary Sensory and Autonomic Neuropathies, Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT00792766 2013-09-18

Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)

Phase 1/2 Completed

Tuberous Sclerosis, Angiolipoma

NCT01031901 2012-02-27

Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

Phase 1 Completed

Neurofibroma, Tuberous Sclerosis, Neurofibromatoses, Angiofibroma

NCT00490789 2008-04-30

TESSTAL

Phase 2 Unknown

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT00457808 2007-04-09

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

Phase 2 Completed

Tuberous Sclerosis, Lymphangioleiomyomatosis